YDR089W Antibody

What is YDR089W and what is its function in yeast cells?

YDR089W is a gene in Saccharomyces cerevisiae (Baker's yeast) that encodes a novel subunit of the vacuole transporter chaperone (VTC) complex, now known as Vtc5. It is one of ten genes in yeast that encode SPX domain-containing proteins, which are critical controllers of phosphate homeostasis in eukaryotes. Vtc5 physically interacts with the VTC complex and plays a crucial role in accelerating the accumulation of inorganic polyphosphate (polyP) synthesized by this complex .

The VTC complex, including Vtc5, is located in the membrane of the acidocalcisome- and lysosome-like vacuole and in the endoplasmic reticulum (ER). This complex couples the synthesis of polyP to its translocation across the membrane, thereby sequestering polyP inside the vacuole lumen and preventing potentially toxic accumulation in the cytosol .

How should researchers validate the specificity of YDR089W antibody?

To validate YDR089W antibody specificity, researchers should employ the knockout validation approach. Following YCharOS characterization protocols, a Western blot should be performed using both wild-type yeast cell lysate (expressing YDR089W) and knockout cell lysate. A specific antibody will show bands only in the wild-type lane .

For greater confidence in specificity, researchers should consider the following validation steps:

• Immunoprecipitation followed by mass spectrometry

• Testing on multiple yeast strains with varying expression levels

• Competitive binding assays with recombinant YDR089W protein

• Cross-reactivity testing with other SPX domain-containing proteins

If multiple bands appear in wild-type samples, they may represent splice isoforms, multimers, or post-translationally modified forms of the protein, which requires further characterization .

What are the standard applications of YDR089W antibody in research?

The YDR089W antibody has been tested and validated for several applications including:

• ELISA (Enzyme-Linked Immunosorbent Assay) - For quantitative detection of YDR089W protein

• Western Blot (WB) - For protein identification in cell lysates

Researchers can also use this antibody for:

• Immunoprecipitation - To isolate and concentrate the YDR089W protein from complex mixtures

• Immunofluorescence - To visualize the localization of YDR089W/Vtc5 in yeast cells

Each application requires specific optimization of antibody concentration, incubation times, and buffer conditions to maximize signal-to-noise ratio and ensure reproducible results.

What are the optimal storage conditions for YDR089W antibody?

The YDR089W antibody should be stored at -20°C or -80°C upon receipt. Repeated freeze-thaw cycles should be avoided as they can lead to antibody degradation and loss of binding efficacy .

The antibody is typically supplied in a storage buffer containing:

• 50% Glycerol

• 0.01M PBS (pH 7.4)

• 0.03% Proclin 300 as a preservative

For short-term use (within 1-2 weeks), aliquots can be stored at 4°C. For long-term storage, it is recommended to prepare small working aliquots to minimize freeze-thaw cycles.

How does the VTC complex, including Vtc5 (YDR089W), regulate phosphate homeostasis in yeast?

The VTC complex, including Vtc5 (encoded by YDR089W), plays a pivotal role in cellular phosphate homeostasis through several mechanisms:

• PolyP synthesis and storage: The VTC complex synthesizes polyP and translocates it into the vacuole, creating a phosphate reserve that can be mobilized during phosphate starvation .

• Cytosolic Pi regulation: This process actively influences the steady-state levels of cytosolic inorganic phosphate (Pi). Overexpression of Vtc5 hyperactivates polyP production and triggers the phosphate starvation response via the PHO pathway, demonstrating its regulatory role .

• Buffering function: PolyP synthesis serves as a buffer for transient fluctuations in cytosolic Pi levels. When cells are shifted from Pi-rich media to Pi-starvation conditions, polyP is degraded, releasing phosphate and influencing the kinetics of changes in cytosolic Pi .

Research data has shown that deletion of VTC5 reduces polyP accumulation both in vivo and in vitro, while its overexpression enhances polyP production. Interestingly, the Vtc5-induced starvation response can be reversed by genetically or pharmacologically inhibiting polyP synthesis, suggesting that polyP synthesis itself, rather than Vtc5 directly, regulates the PHO pathway .

What methodological approaches should be used for immunoprecipitation studies with YDR089W antibody?

For successful immunoprecipitation studies with YDR089W antibody, researchers should follow this optimized protocol based on published methodologies:

• Vacuole isolation: Isolate approximately 200 μg of vacuoles from yeast cells following established protocols.

• Sample preparation:

  • Dilute isolated vacuoles into 1 ml of PS buffer

  • Sediment by centrifugation (7000 × g, 7 min, 4°C)

  • Resuspend pellets in 500 μl of solubilization buffer (10 mM PIPES, pH 6.8, 200 mM sorbitol, 5% glycerol, 0.5% Triton X-100)

  • Allow lysis to proceed for 20 min at 4°C with gentle shaking

  • Remove insoluble material by centrifugation (20,000 × g, 20 min, 4°C)

• Immunoprecipitation procedure:

  • Add anti-YDR089W antibodies (3 μl) to the solubilized samples

  • Add 30 μl of protein G-agarose beads pre-equilibrated in solubilization buffer

  • Incubate on a rotating shaker (1 h, 4°C)

  • Wash beads with solubilization buffer

  • Elute immunoprecipitated proteins by incubating beads in 2× SDS-PAGE sample loading buffer (10 min, 65°C)

This approach efficiently captures Vtc5 along with its interacting partners in the VTC complex, allowing researchers to study protein-protein interactions and complex formation.

How can researchers distinguish between specific binding and background signals when using YDR089W antibody?

Distinguishing specific binding from background signals requires a comprehensive approach:

• Knockout controls: The most definitive control is comparing signals between wild-type and YDR089W knockout strains. Specific signals should be absent in knockout samples .

• Competing peptide controls: Pre-incubate the antibody with excess recombinant YDR089W protein before application to samples. Specific signals should be significantly reduced or eliminated.

• Signal-to-noise optimization:

  • Titrate antibody concentration to find the optimal dilution that maximizes specific signal while minimizing background

  • Optimize blocking conditions (both blocking agent and duration)

  • Increase wash stringency for high-background samples

• Multiple detection methods: Validate findings using alternative detection techniques. If a protein band is detected by Western blot, confirm its identity using mass spectrometry or another antibody targeting a different epitope of YDR089W.

• Quantitative assessment: Calculate signal-to-noise ratios and set objective thresholds for positive detection. For Western blots, densitometry analysis comparing band intensity between specific and non-specific regions provides quantitative data.

What considerations are important when studying the relationship between Vtc5 (YDR089W) and polyphosphate metabolism?

When investigating the relationship between Vtc5 and polyphosphate metabolism, researchers should consider:

• Expression level effects: Overexpression of Vtc5 hyperactivates polyP production, while deletion reduces polyP accumulation. Carefully control Vtc5 expression levels in experimental systems .

• Growth conditions impact: PolyP metabolism is highly sensitive to phosphate availability. Standardize phosphate concentrations in growth media and document any changes in experimental conditions.

• VTC complex interactions: Vtc5 functions as part of the larger VTC complex. Consider the expression and activity of other complex components (Vtc1, Vtc2, Vtc3, and Vtc4) when interpreting results .

• Subcellular localization: The VTC complex localizes to both vacuolar membranes and the ER, with different subunit compositions at each location. Use fluorescent tagging or subcellular fractionation to determine the precise location of Vtc5 activity .

• Analytical techniques: Employ multiple methods to measure polyP levels, including:

  • Enzymatic assays using recombinant exopolyphosphatase (PPX)

  • Gel electrophoresis for polyP chain length distribution

  • 31P-NMR spectroscopy for in vivo measurements

  • Fluorescent microscopy with DAPI staining for polyP visualization

• PHO pathway activation: Monitor the activation status of the PHO pathway, as Vtc5-induced polyP synthesis can trigger phosphate starvation responses .

What are the common technical challenges when using YDR089W antibody in Western blots?

Researchers frequently encounter several technical challenges when using YDR089W antibody in Western blotting:

• Variable protein extraction efficiency: YDR089W/Vtc5 is a transmembrane protein localized to the vacuolar membrane, making complete extraction challenging. Use specialized membrane protein extraction buffers containing appropriate detergents (0.5% Triton X-100) to improve solubilization .

• Post-translational modifications: As Vtc5 may undergo phosphorylation or other modifications that affect its migration pattern, researchers should be prepared to observe multiple bands. Use phosphatase treatments or specific inhibitors to confirm modification status.

• Cross-reactivity: The antibody may cross-react with other SPX domain-containing proteins. Validate specificity using knockout controls and competitive binding assays.

• Detection sensitivity: As a regulatory protein, Vtc5 may be expressed at relatively low levels under certain conditions. Consider using enhanced chemiluminescence (ECL) substrates with higher sensitivity or fluorescent secondary antibodies for improved detection.

• Sample preparation: Avoid excessive heating of samples (>70°C) as this may cause aggregation of membrane proteins like Vtc5, leading to poor resolution in gels.

How can researchers engineer yeast systems to study YDR089W function?

To engineer yeast systems for studying YDR089W function, researchers can employ several approaches:

• Gene deletion and complementation:

  • Create YDR089W knockout strains using homologous recombination

  • Complement with wild-type or mutated versions under native or inducible promoters

  • Use plasmid-based expression systems for controlled reintroduction

• Fusion protein strategies:

  • Generate GFP or other fluorescent protein fusions for localization studies

  • Create epitope-tagged versions (HA, FLAG, etc.) for improved detection and immunoprecipitation

  • Ensure fusion constructs maintain protein functionality through complementation assays

• Inducible expression systems:

  • Use GAL1 promoter for controlled expression by galactose induction

  • Employ tetracycline-responsive promoters for fine-tuned expression levels

  • Validate expression levels by Western blotting with YDR089W antibody

• CRISPR-Cas9 genome editing:

  • Introduce specific mutations to study structure-function relationships

  • Create regulatory element modifications to alter expression patterns

  • Generate conditional alleles for temporal control of gene function

This approach has been successful in related research, where yeast cells were engineered to display specific binding nanobodies on their cell surface, demonstrating the versatility of yeast as an expression system .

What approaches should researchers use to study YDR089W interactions with other VTC complex components?

To comprehensively study YDR089W interactions with other VTC complex components, researchers should employ multiple complementary approaches:

• Co-immunoprecipitation (Co-IP): Use YDR089W antibody to pull down the protein and its interacting partners. Analyze the precipitated material by Western blotting with antibodies against other VTC components (Vtc1, Vtc2, Vtc3, and Vtc4) .

• Yeast two-hybrid assays: Screen for direct protein-protein interactions between Vtc5 and other VTC components. This can identify specific domains involved in these interactions.

• Bimolecular Fluorescence Complementation (BiFC): Fuse complementary fragments of fluorescent proteins to Vtc5 and potential interacting partners to visualize interactions in living cells.

• Proximity-dependent labeling: Use BioID or APEX2 fusions to Vtc5 to identify proximal proteins in the native cellular environment.

• Quantitative mass spectrometry: Perform SILAC or TMT-based proteomics on immunoprecipitated samples to quantify interaction strengths and dynamics under different conditions.

• Genetic interaction analysis: Study synthetic genetic interactions by creating double mutants of VTC5 with other VTC complex genes to identify functional relationships.

• Structural biology approaches: When possible, purify components for structural studies using X-ray crystallography or cryo-EM to determine physical interaction interfaces.

How might the SPX domain of YDR089W compare to SPX domains in other proteins?

The SPX domain in YDR089W/Vtc5 shares structural and functional characteristics with SPX domains in other proteins, yet possesses unique features:

Further structural and functional studies specifically targeting the SPX domain of YDR089W are needed to fully elucidate its unique properties within the broader family of SPX domain-containing proteins.

What potential applications exist for yeast-produced antibodies in research?

Recent advances in yeast-based antibody production systems offer several promising applications for research:

• Safe and economical production: Yeast cells provide a safe, low-cost alternative to current antibody production technologies, making them particularly valuable for research settings with limited resources .

• Scalable production: Unlike antibody collection from patient samples, yeast-based systems can be scaled up efficiently in bioreactors while maintaining consistent quality.

• Engineered binding specificities: Yeast can be genetically engineered to display specific binding nanobodies on their cell surface, enabling the development of highly specific detection tools. This approach has been successfully demonstrated with norovirus-binding nanobodies, achieving capture efficiencies up to 91.3% .

• Rapid response to emerging pathogens: The ability to produce neutralizing antibodies in yeast using genetic information from recovered patients offers a potential rapid-response system for emerging infectious diseases, as demonstrated with SARS-CoV-2 antibodies .

• Point-of-care diagnostics: Engineered yeast cells displaying antibodies or nanobodies could serve as biosensors for detecting pathogens or biomarkers in research or clinical samples with high sensitivity (detection limits as low as 0.071 pg/g have been reported) .

These applications highlight the versatility of yeast-based systems for both antibody production and as antibody-displaying whole-cell biosensors for research applications.